Ranibizumab [347396-82-1]

TargetMol Chemicals

Ranibizumab

9

347396-82-1

Antibody

Research Use Only

Ranibizumab

149.19KD

Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumabs ability to selectively target and neutralize VEGF-A isoforms has made it a crucial component of research and treatment strategies for wet wet age-related macular degeneration (AMD).

3 years

-20°C

12352203